Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $18.0700 (-0.44%) ($17.9600 - $18.7200) on Thu. Jan. 26, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.12% (three month average) | RSI | 60 | Latest Price | $18.0700(-0.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(61%) IBB(61%) XBI(59%) IWO(56%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -2.06% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-6%) GDXJ(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.06% (StdDev 4.12%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
5 Day Moving Average | $18.23(-0.88%) | 10 Day Moving Average | $18.25(-0.99%) | 20 Day Moving Average | $17.93(0.78%) | To recent high | -3.7% | To recent low | 45% | Market Cap | $1.122b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |